Interleukin-10/NN
stabilizes/VBZ
inhibitory/JJ
kappaB-alpha/NN
in/IN
human/JJ
monocytes/NNS
./.

Interleukin-10/NN
(/(
IL-10/NN
)/)
protects/VBZ
animals/NNS
from/IN
lethal/JJ
endotoxemia/NN
./.
=====
This/DT
beneficial/JJ
effect/NN
is/VBZ
mediated/VBN
,/,
in/IN
part/NN
,/,
by/IN
inhibition/NN
of/IN
inflammatory/JJ
cytokine/NN
production/NN
,/,
including/VBG
tumor/NN
necrosis/NN
factor-alpha/NN
(/(
TNF-alpha/NN
)/)
./.
=====
Evidence/NN
suggests/VBZ
that/IN
IL-10/NN
may/MD
inhibit/VB
activation/NN
of/IN
the/DT
transcription/NN
factor/NN
nuclear/JJ
factor-kappaB/NN
(/(
NF-kappaB/NN
)/)
through/IN
an/DT
unknown/JJ
mechanism/NN
./.
=====
NF-kappaB/NN
activation/NN
in/IN
response/NN
to/TO
inflammatory/JJ
signals/NNS
is/VBZ
dependent/JJ
upon/IN
degradation/NN
of/IN
its/PRP$
associated/VBN
inhibitory/JJ
peptide/NN
,/,
inhibitory/JJ
kappaB-alpha/NN
(/(
IkappaB-alpha/NN
)/)
./.
=====
We/PRP
hypothesized/VBD
that/IN
IL-10/NN
prevents/VBZ
human/JJ
monocyte/NN
NF-kappaB/NN
activation/NN
and/CC
resultant/JJ
TNF-alpha/NN
production/NN
by/IN
stabilization/NN
of/IN
IkappaB-alpha/NN
./.
=====
The/DT
purpose/NN
of/IN
this/DT
study/NN
was/VBD
to/TO
determine/VB
the/DT
effect/NN
of/IN
IL-10/NN
on/IN
lipopolysaccharide/NN
(/(
LPS/NN
)/)
-induced/JJ
human/JJ
monocyte/NN
TNF-alpha/NN
production/NN
,/,
NF-kappaB/NN
activation/NN
,/,
and/CC
IkappaB-alpha/NN
degradation/NN
./.
=====
Monocytes/NNS
were/VBD
isolated/VBN
from/IN
human/JJ
donors/NNS
./.
=====
Cells/NNS
were/VBD
stimulated/VBN
with/IN
endotoxin/NN
(/(
LPS/NN
,/,
100/CD
ng/mL/NN
)/)
with/IN
and/CC
without/IN
human/JJ
IL-10/NN
(/(
10/CD
ng/mL/NN
)/)
./.
=====
Following/VBG
stimulation/NN
,/,
TNF-alpha/NN
was/VBD
measured/VBN
in/IN
cell/NN
supernatants/NNS
by/IN
ELISA/NN
,/,
NF-kappaB/NN
activity/NN
by/IN
electrophoretic/JJ
mobility/NN
shift/NN
assay/NN
,/,
and/CC
IkappaB-alpha/NN
levels/NNS
by/IN
Western/NN
blot/NN
./.
=====
We/PRP
observed/VBD
that/IN
after/IN
LPS/NN
stimulation/NN
of/IN
human/JJ
monocytes/NNS
,/,
TNF-alpha/NN
increased/VBD
to/TO
798+/-67/CD
pg/mL/NN
(/(
p/NN
</JJR
.001/CD
versus/CC
control/NN
)/)
./.
=====
IL-10/NN
attenuated/VBD
LPS-stimulated/JJ
TNF-alpha/NN
production/NN
(/(
297+/-54/CD
;/:
p/NN
</JJR
.001/CD
versus/CC
LPS/NN
alone/RB
)/)
./.
=====
After/IN
LPS/NN
stimulation/NN
in/IN
human/JJ
monocytes/NNS
,/,
IkappaB-alpha/NN
protein/NN
levels/NNS
decreased/VBD
,/,
and/CC
NF-kappaB/NN
DNA/NN
binding/NN
increased/VBD
./.
=====
IL-10/NN
pretreatment/NN
prevented/VBD
LPS-induced/JJ
decreases/NNS
in/IN
IkappaB-alpha/NN
protein/NN
levels/NNS
and/CC
attenuated/VBD
NF-kappaB/NN
DNA/NN
binding/NN
./.
=====
IL-10/NN
appears/VBZ
to/TO
prevent/VB
activation/NN
of/IN
NF-kappaB/NN
by/IN
preserving/VBG
IkappaB-alpha/NN
protein/NN
levels/NNS
,/,
leading/VBG
to/TO
a/DT
reduction/NN
in/IN
TNF-alpha/NN
release/NN
./.